ABIOMED Income Statement
View: Annual | Quarterly
| Mar 08 | Mar 07 | Mar 06 | |
|---|---|---|---|
| Revenue | 58.9 | 50.7 | 43.7 |
| Cost of Goods Sold | 15.1 | 12.0 | 11.7 |
| Gross Profit | 43.9 | 38.6 | 32.0 |
| Gross Profit Margin | 74.4% | 76.3% | 73.3% |
| SG&A Expense | 74.2 | 63.2 | 59.5 |
| Depreciation & Amortization | 6.1 | 3.9 | 2.7 |
| Operating Income | (36.5) | (28.5) | (30.3) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | (3.9) | 1.1 | 1.2 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | (40.4) | (27.4) | (29.1) |
| Income Taxes | 0.5 | 0.5 | 0.4 |
| Net Income After Taxes | (40.9) | (27.9) | (29.5) |
| Continuing Operations | (40.9) | (27.9) | (29.5) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (40.9) | (27.9) | (29.5) |
| Total Net Income | (40.9) | (27.9) | (29.5) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (1.26) | (1.03) | (1.15) |
| Dividends per Share | -- | -- | -- |






